Catalyst Wire Dossier Catalyst Wire Dossier

Universal CD19 CAR-γδ T cell infusion

CAR-γδ T cell therapy targeting CD19
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Universal CD19 CAR-γδ T cell infusion, covering 2026-03-24 to 2026-03-24. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of Universal CD19 CAR-γδ T Cell Infusion in the Treatment of Relapsed/Refractory Acute B Lymphoblastic Leukemia [Phase 1]

See pricing